Neil Morton serves as Executive at APRICUS BIOSCIENCES, INC., where they oversee executive responsibilities. Since joining the company, Neil Morton has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2019 involved selling 32,705 shares valued at $7.5K.
Neil Morton currently holds 100,158 shares of APRICUS BIOSCIENCES, INC. (APRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Morton has been a net neutral trader of APRI stock. They have purchased $0 and sold $0 worth of shares.
Neil Morton's most recent insider trade was on Jan 23, 2019, when they sold 32,705 shares at $0.23 per share.
Get notified when new Form 4 filings are submitted
| $0.31 |
| Discretionary |
| Jan 1, 2018 | APRI | $4.0K | Payment | 2,194 | $1.84 | Discretionary |
| Sep 5, 2017 | APRI | $22.0K | Payment | 14,093 | $1.56 | Discretionary |
| Jun 1, 2017 | APRI | $0 | Award | 75,000 | $N/A | Discretionary |
| Feb 15, 2017 | APRI | $2.3K | Payment | 831 | $2.78 | Discretionary |
| Jan 5, 2017 | APRI | $0 | Award | 75,000 | $N/A | Discretionary |
| May 20, 2016 | APRI | $0 | Award | 100,000 | $N/A | Discretionary |
| Apr 25, 2016 | APRI | $0 | Award | 100,000 | $N/A | Discretionary |
| Apr 25, 2016 | APRI | $0 | Award | 0 | $N/A | Discretionary |